150 related articles for article (PubMed ID: 8862945)
1. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
Vijayalingam S; Parthiban A; Shanmugasundaram KR; Mohan V
Diabet Med; 1996 Aug; 13(8):715-9. PubMed ID: 8862945
[TBL] [Abstract][Full Text] [Related]
2. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
4. Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.
Shelgikar KM; Naik SS; Khopkar M; Bhat DS; Raut KN; Joglekar CV; Gerard ME; Yajnik CS
Diabet Med; 1997 Sep; 14(9):757-61. PubMed ID: 9300225
[TBL] [Abstract][Full Text] [Related]
5. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients.
Atli T; Keven K; Avci A; Kutlay S; Turkcapar N; Varli M; Aras S; Ertug E; Canbolat O
Arch Gerontol Geriatr; 2004; 39(3):269-75. PubMed ID: 15381345
[TBL] [Abstract][Full Text] [Related]
7. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
8. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L
Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
10. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats.
Murugan P; Pari L
J Ethnopharmacol; 2007 Sep; 113(3):479-86. PubMed ID: 17693046
[TBL] [Abstract][Full Text] [Related]
11. Pro-, antioxidant and rheologic studies in the blood of type 2 diabetic patients.
Matkovics B; Kotormán M; Varga IS; Hai DQ; Salgó L; Novák Z
Acta Physiol Hung; 1997-1998; 85(2):107-12. PubMed ID: 9706304
[TBL] [Abstract][Full Text] [Related]
12. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
Guerrero-Romero F; Rodríguez-Morán M
Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes.
Pari L; Saravanan R
Chem Biol Interact; 2007 Aug; 169(1):15-24. PubMed ID: 17537413
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus.
Ahmed FN; Naqvi FN; Shafiq F
Ann N Y Acad Sci; 2006 Nov; 1084():481-9. PubMed ID: 17151323
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system].
Wang XL; Lu JM; Pan CY; Mu YM; Dou JT; Ba JM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):674-7. PubMed ID: 16681924
[TBL] [Abstract][Full Text] [Related]
17. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
[TBL] [Abstract][Full Text] [Related]
18. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
[TBL] [Abstract][Full Text] [Related]
20. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
